The US government’s solution to the monkeypox vaccine shortage is so far only causing headaches for strained public health departments as the outbreak continues to grow in scale and scope.
The so-called dose-sparing strategy allows those giving out the vaccine to use just one-fifth of what’s traditionally given in attempt to squeeze more doses out of the existing supply. While sounding good in theory, the move requires “a significant shift in operations” for local health departments, Allison Arwady, Chicago’s public health commissioner, said during a Big Cities Health Coalition meeting. And it could be weeks before clinicians actually start employing this ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
